866-997-4948(US-Canada Toll Free)

Masimo Corporation (MASI) - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Nov 2012

Category :

Surgical Equipment

No. of Pages : 41 Pages


Masimo Corporation (Masimo) is a global medical technology company that deals with manufacturing and distribution of non-invasive patient monitoring technologies such as medical devices and a broad range of sensors to improve patient care. The companys key products include pulse oximeters, patient monitors, patient cables, central monitoring systems, specialty sensors, circuit boards, remote-alarm and monitoring solutions. In addition, Masimo offers remote monitoring and clinician notification solutions such as the Masimo Patient SafetyNet. Its products are sold directly to hospitals and the emergency medical services (EMS) market through a network of distributors as well as direct sales representatives. Priority markets include the US, Asia-Pacific and Europe.

Masimos business strategy is to improve and develop new product ranges and maintaining the companys financial strength. Masimo also follows a strategy of making acquisitions and collaborations with others in the healthcare industry for ensuring development, promotion and reach of its products in other geographies. As a part of the strategy, the company has acquired Spire Semiconductor and SEDLine, Inc. among others. It has established alliances with Sana Kliniken, GE Healthcare, Biolight, Philips, Oridion and others. The company is headquartered in California, the US.

This report is a source for data, analysis and actionable intelligence on the Masimo Corporation portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 4
List of Figures 4
Masimo Corporation - Business Description 5

Key Facts 6
Masimo Corporation - Major Products and Services 7
Masimo Corporation Pipeline Products by Equipment Type 9
Masimo Corporation Pipeline Products by Development Stage 11
Masimo Corporation Pipeline Products by Therapy Area 13
Masimo Corporation Pipeline Products by Trial Phase 15
Masimo Corporation Pipeline Products by Milestone Summary 17
2012 Radical-7 Pulse CO-Oximetry Device 19
2012 Radical-7 Pulse CO-Oximetry Device Product Status 19
2012 Radical-7 Pulse CO-Oximetry Device Product Description 19
2012 Radical-7 Pulse CO-Oximetry Device Clinical Trial 19
Halo Index 21
Halo Index Product Status 21
Halo Index Product Description 21
In Vivo Adjustment 22
In Vivo Adjustment Product Status 22
In Vivo Adjustment Product Description 22
Rainbow Universal ReSposable SuperSensor 23
Rainbow Universal ReSposable SuperSensor Product Status 23
Rainbow Universal ReSposable SuperSensor Product Description 23
Rainbow Universal ReSposable SuperSensor Product Milestone 23
SpfO2 25
SpfO2 Product Status 25
SpfO2 Product Description 25
SpfO2 Product Milestone 25
Masimo Corporation - Key Competitors 27
Masimo Corporation - Key Employees 28
Masimo Corporation - Key Employee Biographies 29
Masimo Corporation - Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 33
Masimo Corporation, Recent Developments 33
Nov 06, 2012: Skagit Valley Hospital Standardizes On Masimo SET Measure-Through Motion And Low Perfusion Pulse Oximetry 33
Oct 18, 2012: Masimo Presents Multiple New Clinical Studies Of Masimo Noninvasive Patient Monitoring Technologies At ASA Annual Meeting 33
Oct 09, 2012: GE Healthcare Integrates New FDA-Cleared Masimo SET uSpO2 Pulse Oximetry Cable Into Its ApexPro Telemetry Systems 34
Oct 01, 2012: Hamilton Medical Center Updates With Masimo Patient Monitoring Technologies 35
Sep 24, 2012: Masimo Oximeters And Neonatal Sensors Receive FDA 510(k) Clearance With Labeling For Use In Newborn Screening For CCHD 36
Sep 12, 2012: Masimo Announces Easton Hospital Adds Its Patient SafetyNet System And rainbow Pulse CO-Oximetry For Noninvasive Patient Monitoring 37
Aug 29, 2012: Masimo Installs Patient SafetyNet At Medical Center Of Princeton University 37
Aug 01, 2012: Masimo Reports Revenue Of $122.8m In Q2 2012 37
Jul 26, 2012: New Study Reveals Wide Variation In Blood Transfusion Practices During Surgery 38
Jul 17, 2012: Masimo Reports Findings From Meta-analysis Studies Of Pulse Oximetry Screening In Combating Congenital Heart Disease 39

Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Table


Masimo Corporation, Key Facts 1
Masimo Corporation Key Pipeline Products by Equipment Type 1
Masimo Corporation Key Pipeline Products by Development Stage 1
Masimo Corporation Key Pipeline Products by Trial Phase 1
Masimo Corporation, Key Facts 6
Masimo Corporation, Major Products and Services 7
Masimo Corporation Number of Pipeline Products by Equipment Type 9
Masimo Corporation Pipeline Products by Equipment Type 10
Masimo Corporation Number of Pipeline Products by Development Stage 11
Masimo Corporation Pipeline Products by Development Stage 12
Masimo Corporation Pipeline Products by Therapy Area 14
Masimo Corporation Number of Pipeline Products by Trial Phase 15
Masimo Corporation Pipeline Products by Trial Phase 16
Masimo Corporation Number of Pipeline Products By Milestone Summary 17
Masimo Corporation Pipeline Products by Milestone Summary 18
2012 Radical-7 Pulse CO-Oximetry Device - Product Status 19
2012 Radical-7 Pulse CO-Oximetry Device - Product Description 19
2012 Radical-7 Pulse CO-Oximetry Device - Determination of the Physiological Reference Values of Trend of Hemoglobin in the Post-partum Period After Spontaneous Vaginal Delivery. A Sequential Pilot Study Using the Noninvasive Continuous Technology of SpHb 19
Halo Index - Product Status 21
Halo Index - Product Description 21
In Vivo Adjustment - Product Status 22
In Vivo Adjustment - Product Description 22
Rainbow Universal ReSposable SuperSensor - Product Status 23
Rainbow Universal ReSposable SuperSensor - Product Description 23
Rainbow Universal ReSposable SuperSensor - Product Milestone 23
SpfO2 - Product Status 25
SpfO2 - Product Description 25
SpfO2 - Product Milestone 25
Masimo Corporation, Key Employees 28
Masimo Corporation, Key Employee Biographies 29
Masimo Corporation, Other Locations 30
Masimo Corporation, Subsidiaries 31

List of Chart


Masimo Corporation Pipeline Products by Equipment Type 9
Masimo Corporation Pipeline Products by Development Stage 11
Masimo Corporation Pipeline Products by Therapy Area 13
Masimo Corporation Pipeline Products by Trial Phase 15
Masimo Corporation Pipeline Products by Milestone Summary 17

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *